PLX (STOCKS)
Protalix BioTherapeutics, Inc. Common Stock
$2.581300
-0.118700 (-4.40%)
Prev close: $2.700000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Dror Bashan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $210.29M
- Employees
- 213
- P/E (TTM)
- 11.50
- P/B (TTM)
- 2.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.05 | $-0.01 | +0.0601 | +595.05% |
|
Mar 2026 (Q1)
|
$0.22 | $-0.01 | +0.2301 | +2,278.22% |
|
Dec 2025 (Q4)
|
$-0.07 | $0.01 | -0.0751 | -1,472.55% |
|
Sep 2025 (Q3)
|
$0.03 | $0.06 | -0.0256 | -46.04% |